Personalized Activation Letter for High Blood Pressure
Trial Summary
What is the purpose of this trial?
The BP Activate Study aims to assess the effectiveness of the BP Report letter with personalized BP medication recommendations, compared with Control letters and no intervention, at shortening time to appointment, time to visit, time to medication change, and time to achievement of BP goal.
Research Team
Mark Pletcher, MD MPH
Principal Investigator
University of California, San Francisco
Eligibility Criteria
This trial is for primary care patients with high blood pressure (SBP>140 or DBP>90) seen in a general internal medicine clinic within the last 2 years, where medication intensification is needed. It's not for those who don't speak English or whose provider opts them out.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Intervention
Participants receive either the BP Activate Report Letter, Control Letter, or no intervention
Follow-up
Participants are monitored for time to medication change or BP control
Treatment Details
Interventions
- BP Activate Letter
- Control Letter
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of California, San Francisco
Lead Sponsor